Generic Name
Labetalol
FDA approval date: August 03, 1998
Classification: beta-Adrenergic Blocker
Form: Injection, Tablet
What is Labetalol?
Labetalol HCl Injection is indicated in severe hypertension, to lower blood pressure. Labetalol Hydrochloride is a beta-adrenergic blocker. Labetalol HCl Injection is indicated in severe hypertension, to lower blood pressure.
Approved To Treat
Top Global Experts
There are no experts for this drug
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment
Related Latest Advances
There is no latest advances for this treatment